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White spot syndrome virus (WSSV) is a large DNA virus infecting shrimp and other crustaceans. The virus particles contain
at least five major virion proteins, of which three (VP26, VP24, and VP15) are present in the rod-shaped nucleocapsid and two
(VP28 and VP19) reside in the envelope. The mode of entry and systemic infection of WSSV in the black tiger shrimp, Penaeus
monodon, and the role of these proteins in these processes are not known. A specific polyclonal antibody was generated
against the major envelope protein VP28 using a baculovirus expression vector system. The VP28 antiserum was able to
neutralize WSSV infection of P. monodon in a concentration-dependent manner upon intramuscular injection. This result
suggests that VP28 is located on the surface of the virus particle and is likely to play a key role in the initial steps of the
systemic WSSV infection in shrimp. © 2001 Academic Press
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White spot syndrome virus (WSSV) is a major disease
agent of penaeid shrimp in Southeast Asia, the Indian
continent, and in South and Central America (Rosenberg,
2000). The disease is caused by an ovoid-to-bacilliform
virus with a rod-shaped nucleocapsid and a tail-like
appendix at one end of the virion (Durand et al., 1997;
Nadala et al., 1998). The virus contains a double-
stranded DNA with an estimated size of 290 kbp (Yang et
al., 1997). Genetic analysis indicates that WSSV is a
representative of a new virus group provisionally named
whispovirus (Van Hulten et al., 2000b; Tsai et al., 2000).
WSSV has a broad host range, infecting several crus-
tacean species, like shrimp, crab, and crayfish (Wang et
al., 1998). Little is known about WSSV infection and
morphogenesis in vivo. Upon infection per os, infected
cells are observed first in the stomach, gill, and cuticular
epidermis of the shrimp. The infection subsequently
spreads systemically in the shrimp to other tissues of
mesodermal and ectodermal origin (Chang et al., 1996).
Research on virus replication and virion morphogenesis
shows that DNA replication and de novo envelope for-
mation take place in the nucleus (Durand et al., 1997;
Wang et al., 2000). The mechanism of virus entry into the
shrimp and of the spread of the virus in the crustacean
body is not known.
The virus particle consists of at least five major pro-
teins with estimated sizes of 28 kDa (VP28), 26 kDa1 To whom correspondence and reprint requests should be ad-
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228(VP26), 24 kDa (VP24), 19 kDa (VP19), and 15 kDa (VP15).
VP28 and VP19 are associated with the virion envelope
and VP26, VP24, and VP15 with the nucleocapsid (Van
Hulten et al., 2000c). Amino acid analysis of VP28, VP26
and VP24 indicated that these proteins have about 40%
amino acid identity and that their genes may have
evolved from a common ancestral gene (Van Hulten et
al., 2000a). The role of the envelope and its proteins in
the establishment of the systemic infection process has
not been determined.
Neutralization experiments have often been performed
to study the role of virion proteins or their domains in the
infection process. Neutralizing antibodies bind to enve-
lope spikes on the virion and prevent attachment of the
virus to the cell surface, cell entry, or virus uncoating
(Burton et al., 2000). For many vertebrate viruses like
poxviruses (Galmiche et al., 1999) and hepadnaviruses
(Sunyach et al., 1999) in vitro neutralization experiments
involving cell cultures (plaque reduction assays) have
been used for this purpose. For invertebrate baculovi-
ruses, in vitro neutralization experiments have been ex-
ploited to show that Autographa californica nucleopoly-
hedrovirus (AcMNPV) can be neutralized by complexing
the budded virions with specific antibodies against the
viral envelope protein (GP64) (Volkman and Goldsmith,
1985). These authors showed that the mechanism of
neutralization is by inhibition of virus entry and adsorp-
tive endocytosis. However, standardized (primary)
shrimp cell cultures are not available and therefore an in
vivo approach is followed.In vivo neutralization experiments have been widely
used for many vertebrate viruses and have even led to
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229NEUTRALIZATION OF WSSV INFECTION IN SHRIMPpassive immunization strategies. When combined with
the use of monoclonal antibodies, this strategy has been
used to identify the virion protein epitope(s) involved in
the neutralization (e.g., Schofield et al., 2000). In vivo
neutralization assays have also been successfully used
in insects, e.g., in inhibiting infection of larvae of the
Douglas fir tussock moth Orgyia pseudotsugata with its
nucleopolyhedrovirus (OpMNPV) using OpMNPV anti-
serum (Martignoni et al., 1980). This strategy has now
been applied to shrimp with the added advantage that it
is as close as possible to the in vivo situation. In this
paper we provide evidence that VP28 is directly involved
in the systemic infection of the shrimp P. monodon by
SSV.
RESULTS
irus titration
A WSSV virus stock was produced in the crayfish P.
larkii by intramuscular injection of purified WSSV. To
etermine the dilution resulting in 90–100% mortality in
he black tiger shrimp P. monodon, an in vivo virus titra-
ion was performed using animals of approximately 1 g in
eight. The virus stock was diluted in steps from 1 3 105
to 5 3 1011 times in 330 mM NaCl as indicated (Fig. 1)
and for each dilution 10 ml was injected intramuscularly
into 10 shrimp. Shrimp that were injected with 330 mM
NaCl served as negative control for the infection. All
shrimp serving as negative control (not shown) and
11
FIG. 1. Titration of WSSV in P. monodon shrimp. Days postinjection
on the ordinate. Ten microliters of a 1 3 105, 1 3 107, 1 3 108, 5 3 10those having received the 5 3 10 virus dilution sur-
vived, whereas mortality due to virus infection occurred
t
ain all groups with a lower virus dilution (Fig. 1). Admin-
istration of virus dilutions of 1 3 105 and 1 3 107 resulted
n almost 100% mortality in a period of 20 days. A delay
n mortality was observed when virus dilutions of 1 3 108
and 5 3 109 were used. The 1 3 108 dilution resulted in
0% final mortality, but the time of mortality was delayed
nd spanned a period of 40 days. The experiment was
epeated with the 1 3 107, the 1 3 108, and the 5 3 109
dilution yielding essentially the same results. The dilu-
tion of 1 3 108 was chosen as the virus dose for further
experiments as this condition was expected to give the
optimal response to the neutralization in terms of mor-
tality reduction.
Antibody against recombinant VP28
The major WSSV envelope protein VP28 was ex-
pressed under control of the polyhedrin promoter in
insect cells using recombinant baculovirus AcMNPV-
WSSVvp28 (Van Hulten et al., 2000c) and was used after
urification to raise specific polyclonal antibodies in rab-
its. The VP28 polyclonal antiserum reacted strongly
ith baculovirus expressed as well as with bacterial
xpressed VP28 (data not shown).
As VP28 shows a considerable degree of amino acid
omology with nucleocapsid proteins VP26 and VP24
Van Hulten et al., 2000a), the specificity of the polyclonal
as tested against purified WSSV virions and WSSV
ucleocapsids (Fig. 2). All major proteins are present in
irus are shown on the abscissa and the accumulated mortality (in %)
3 1011 diluted virus stock was injected.he virion fraction (Fig. 2A, lane 2) and only VP26, VP24
nd VP15 are present in the nucleocapsid fraction (Fig.
rn blot
230 VAN HULTEN ET AL.2A, lane 3). In the Western analysis (Fig. 2B) the VP28
antiserum (1:5000 dilution) shows a clear reaction with
the VP28 present in the WSSV virion (Fig. 2B, lane 2). A
minor reaction was observed with smaller products,
most likely VP28 breakdown products. There was no
reaction with proteins of the WSSV nucleocapsids (Fig.
2B, lane 3). This shows that there is no cross-reactivity of
the VP28 polyclonal antiserum with VP26 or VP24, de-
spite the notable degree of amino acid homology.
WSSV neutralization in vivo
The VP28 polyclonal antiserum was used in an in vivo
neutralization assay in P. monodon. A constant amount of
WSSV was incubated with various antiserum concentra-
tions (Table 1) and injected into shrimp. No shrimp died
in the negative control injected only with 330 mM NaCl
(group 6). The shrimp in the positive control, which were
injected with WSSV only (group 1), showed a 100% mor-
tality at day 23 (Fig. 3). Addition of the preimmune serum
(group 2) resulted in a small initial delay in shrimp mor-
tality, which reached 100% at day 25 (Fig. 3). When the
FIG. 2. (A) Fifteen percent Coomassie brilliant blue-stained SDS–PAG
purified WSSV virions. Lane 3, purified WSSV nucleocapsids. (B) Weste
antiserum is used and detection is performed with the ECL kit.virus was preincubated with a 10-fold dilution of the VP28
antiserum (group 3), shrimp mortality was 100% at day22. Apparently the VP28 antiserum at this dilution is not
able to neutralize the virus. When the VP28 serum is
diluted only two times (group 4) or used undiluted (group
5), none of the shrimp died, indicating that WSSV can be
f purified WSSV. Lane 1, low-molecular-weight protein marker. Lane 2,
of the virions (lane 2) and nucleocapsid (lane 3) of A. VP28 polyclonal
TABLE 1
Constitution of Injection Solutions
Group
No. Type
Injection
(10 ml total)
No.
shrimp
1 Positive control WSSV 10
2 Preimmune serum
control
WSSV 1 9 ml preimmune
serum
15
3 103 dilution of VP28
antiserum
WSSV 1 1 ml VP28
antiserum
15
4 23 dilution of VP28
antiserum
WSSV 1 5 ml VP28
antiserum
15
5 VP28 antiserum WSSV 1 9 ml VP28
antiserum
15
6 Negative control 330 mM NaCl 10
Note. The first column shows the group numbers, the second the
treatment, the third the content of the 10-ml injected volume, and theE gel ofourth the number of shrimp used in each group. The total amount of
WSSV injected is the same for groups 1 to 5.
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231NEUTRALIZATION OF WSSV INFECTION IN SHRIMPneutralized by the VP28 antibodies in a dose-dependent
manner (Fig. 3).
DISCUSSION
To study the role of the major WSSV envelope protein
VP28 in WSSV infection, a specific antiserum was pro-
duced against this protein. As there is a significant de-
gree of homology between the envelope protein VP28
and the nucleocapsid proteins VP26 (41% amino acid
similarity) and VP24 (46% amino acid similarity) (Van
Hulten et al., 2000a), a Western analysis (Fig. 2) was
erformed, confirming the specificity of the VP28 poly-
lonal antiserum for VP28.
A WSSV virus stock was produced from infected P.
larkii. Since an absolute measure of virus activity in
nfectious units cannot be given, we have determined the
ighest virus dilution of the virus stock that results in
lmost 100% mortality upon injection of a fixed volume
10 ml) into shrimp. Shrimp were used for the titration of
he virus stock, as no reliable cell culture system is
vailable to measure WSSV infection and the effect of
eutralization. Since the 1 3 108 dilution of the virus
tock was the lowest dose still resulting in almost 100%
inal mortality (Fig. 1), this dilution was used for neutral-
zation experiments. In the latter experiments (Fig. 3) the
ilution of 1 3 108 resulted in a somewhat quicker
mortality (Fig. 3, group 1: WSSV) than in the titration
experiment (Fig. 1). This difference in response might be
FIG. 3. Neutralization of WSSV infection in P. monodon using VP28
ercentage mortality on the ordinate. Treatments of the five groups usthe consequence of the use of a different batch of
shrimp. However, this does not influence the results ofthe neutralization experiment, as a control (no antiserum)
was included.
To study the role of VP28 in WSSV infection in shrimp,
an in vivo neutralization test was performed. This test
showed that WSSV infection was neutralized by the VP28
polyclonal antiserum (Fig. 3) and that VP28 is involved in
this process. The preimmune serum control resulted in a
small delay of shrimp mortality. This could be due to
compounds present in the serum stimulating the shrimp
defense system. WSSV neutralization using the VP28
polyclonal antiserum was concentration dependent; only
the two highest antibody concentrations used in this
study resulted in neutralization (Fig. 3).
VP28 is the major protein in the WSSV envelope, but its
location in this structure is not known. The neutralizing
activity of the VP28 antiserum shown here might depend
on the relative abundance of this protein on the virion
envelope. However, mere binding of the antibody to the
surface of the virus does not automatically result in virus
neutralization. The existence of nonneutralizing antibod-
ies, which bind to virus without diminishing infectivity,
has long been recognized (Dimmock, 1984). In other
virus systems only anti-envelope antibodies binding to
the envelope spike on the virion will be neutralizing or
show antiviral activity (Burton et al., 2000). Therefore, we
postulate that VP28 or its neutralization domain is lo-
cated in the envelope spike of WSSV virions.
Further research is required to reveal the exact role of
lonal antiserum. Days postinjection are shown on the abscissa and
described in Table 1.VP28 in WSSV infection. Neutralization of viral infectivity
by antibodies is a complex and, as yet, poorly under-
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232 VAN HULTEN ET AL.stood phenomenon. Studies on the functional domains of
proteins suggest that neutralization sites and virus at-
tachment sites are often distinct (Ramsey et al., 1998).
eutralizing antibodies often inhibit a subsequent stage
f infection, which is then responsible for the loss of
nfectivity. There are only a few examples of residues
ithin neutralization epitopes that are also involved in
he attachment of the virus to its cellular receptor (Sun-
ach et al., 1999). For VP28 a similar situation could exist
s for the major envelope protein of the budded viruses
f AcMNPV, where the virus can be neutralized using
ntibodies to GP64 (Volkman et al., 1984). Further studies
ith AcMNPV showed that the mechanism of neutraliza-
ion is not by inhibition of adsorption, but by inhibition of
he fusion of the viral envelope with the cell membrane
Volkman and Goldsmith, 1985). However, alternative
echanisms of neutralization are possible. Inhibition can
lso take place during uncoating of virus or transport of
NA in the nucleus. Furthermore, binding of antibodies
an induce conformational changes in virus proteins and
hese may be relevant for the neutralization process.
The in vivo neutralization experiments on WSSV in P.
onodon with VP28 antibodies suggest that VP28 is
ocated in the “spikes” of the WSSV envelope and this
rotein may thus be involved in the systemic infection of
SSV in shrimp. It cannot be excluded that other WSSV
nvelope proteins, such as VP19, are also involved in this
rocess, either alone or in concert with VP28. Antibodies
gainst VP19 will assist in the elucidation of this point.
uture experiments using in vivo neutralization will dem-
nstrate which part of VP28 is involved in the neutraliza-
ion process and what the role of VP28 in WSSV attach-
ent and entry in the systemic infection is.
MATERIALS AND METHODS
hrimp culture
Cultures of healthy shrimp were performed in a recir-
ulation system at the Laboratory of Fish Culture and
isheries at Wageningen University. For the experiments
hrimp were transferred to an experimental system lo-
ated at the Laboratory of Virology, Wageningen Univer-
ity, and kept in groups of 10–15 individuals in 60-liter
quariums with an individual filter (Eheim, Germany) and
eating (Schego, Germany) at 28°C. P. monodon shrimp
f approximately 1 g were used in the titration and
eutralization experiments.
hite spot syndrome virus stock production
The virus isolate used in this study originates from
nfected P. monodon shrimp imported from Thailand in
1996 and was obtained as described before (Van Hulten
et al., 2000b). Crayfish Procambarus clarkii were injected
intramuscularly with a lethal dose of WSSV using a
26-gauge needle. After one week the hemolymph was
p
wwithdrawn from moribund crayfish and mixed with mod-
ified Alsever solution (Rodriguez et al., 1995) as an anti-
coagulant. The virus was purified by centrifugation at
80,000g for 1.5 h at 4°C on a 20–45% continuous sucrose
gradient in TN (20 mM Tris, 400 mM NaCl, pH 7.4). The
visible virus bands were removed and the virus particles
were subsequently sedimented by centrifugation at
45,000g at 4°C for 1 h. The virus pellet was resuspended
in TE (pH 7.5) and the virus integrity was checked by
electron microscopy. The virus stock was stored at
280°C until use in the experiments.
VP28 polyclonal antibody
The major WSSV structural envelope protein VP28 was
expressed in insect cells using baculovirus AcMNPV-
WSSVvp28 (Van Hulten et al., 2000c). The protein band
containing the VP28 was purified using a Model 491
PrepCell (Bio-Rad) according to the instruction manual.
Fractions were collected using a Model 2110 fraction
collector (Bio-Rad) and analyzed in a silver-stained SDS–
PAGE gel. Western blotting using a polyclonal WSSV
antibody was employed to determine the VP28-contain-
ing fractions. These fractions were pooled and SDS was
removed by dialysis against several volumes of 0.13 TE.
The protein was subsequently concentrated by freeze-
drying and resuspended in 0.13 TE (pH 7.5). The purified
VP28 protein (100 mg) was injected into a rabbit to pro-
duce a polyclonal antibody. The rabbit was boosted with
300 mg of VP28 after 6 weeks and the antiserum was
repared 2 weeks thereafter.
n vivo injection
P. monodon shrimp of approximately 1 g were injected
ntramuscularly with 10 ml of virus solution in 330 mM
aCl in the fourth or fifth tail segment of the shrimp with
29-gauge needle (Microfine B & D). The shrimp were
ubsequently cultured for a period of 40 days and the
ortality was monitored twice daily. For each group
0–15 shrimp were used. Deceased shrimp were moni-
ored for WSSV infection by viewing hemolymph extracts
nder the electron microscope.
eutralization assay
Shrimp of 1 g were injected with WSSV in the presence
r absence of VP28 antibody. A negative (330 mM NaCl)
nd a positive control (virus only) were included (Table
). The total amount of virus administered per shrimp is
onstant in all groups and is equivalent to 10 ml of the
3 108 dilution of the virus stock. The preimmune serum
as included as a control for the effect of the serum on
hrimp mortality. Several dilutions of the antiserum were
ncubated with the virus for 1 h at room temperature,
rior to injection in shrimp. After injection, the shrimp
ere monitored for 28 days and dead shrimp were ex-
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233NEUTRALIZATION OF WSSV INFECTION IN SHRIMPamined for the presence of WSSV by electron micros-
copy.
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